Associations of long-chain ω-3 fatty acids and fish intake with endometrial cancer risk in the VITamins and Lifestyle cohort

American Journal of Clinical Nutrition

Volumn 99, Issue 3, 2014, Pages 599-608

  Brasky, Theodore M ^a   Neuhouser, Marian L ^b   Cohn, David E ^a   White, Emily ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FAMILY HISTORY; FEMALE; FISH INTAKE; FOLLOW UP; FOOD INTAKE; HORMONAL THERAPY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MIDDLE AGED; OBESITY; PARITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RACE DIFFERENCE; REPRODUCTIVE HEALTH; SMOKING;

AGED; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY MASS INDEX; COHORT STUDIES; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENDOMETRIAL NEOPLASMS; FEMALE; FISHES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; OVERWEIGHT; RISK FACTORS; SEAFOOD; SEER PROGRAM; SHELLFISH; WASHINGTON;

EID: 84896882616     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.070524     Document Type: Article

References (50)

1. Wallace AE, Gibson DA, Saunders PT, Jabbour HN. Inflammatory events in endometrial adenocarcinoma. J Endocrinol 2010;206:141-57.
2. Dossus L, Becker S, Rinaldi S, Lukanova A, Tjonneland A, Olsen A, Overvad K, Chabbert-Buffet N, Boutron-Ruault MC, Clavel-Chapelon F, et al. Tumor necrosis factor (TNF)-alpha, soluble TNF receptors and endometrial cancer risk: The EPIC study. Int J Cancer 2011;129:2032-7.
3. Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 2010;17:1007-19.
4. Wang T, Rohan TE, Gunter MJ, Xue X, Wactawski-Wende J, Rajpathak SN, Cushman M, Strickler HD, Kaplan RC, Wassertheil-Smoller S, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev 2011;20:971-7.
5. Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis. Int J Cancer 2013;132:1146-55.
6. Kilic G, Gurates B, Garon J, Kang H, Arun B, Lampley CE, Kurzel R, Ashfaq R. Expression of cyclooxygenase-2 in endometrial adenocarcinoma. Eur J Gynaecol Oncol 2005;26:271-4. (Pubitemid 40879621)
7. Keser SH, Gul AE, Barisik NO, Cakir C, Sensu S, Kandemir NO, Karadayi N. The relationship of COX-2 expression with estrogen receptor, progesterone receptor and prognostic parameters in endometrial carcinomas. J Obstet Gynaecol Res 2010;36:560-6.
8. Fowler JM, Ramirez N, Cohn DE, Kelbick N, Pavelka J, Ben-Shachar I, Morrison C. Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol 2005;192:1262-73. (Pubitemid 40487806)
9. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009;81:187-91.
10. Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, Kosary C, Yu M, Ruhl J, Tatalovich Z, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute, 2013. Available from: http://seer.cancer.gov/csr/1975-2010/.
11. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
12. Brasky TM, Moysich KB, Cohn DE, White E. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort. Gynecol Oncol 2013;128:113-9.
13. Arem H, Neuhouser ML, Irwin ML, Cartmel B, Lu L, Risch H, Mayne ST, Yu H. Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study. Eur J Nutr 2013;52:1251-60.
14. Fernandez E, Chatenoud L, La Vecchia C, Negri E, Franceschi S. Fish consumption and cancer risk. Am J Clin Nutr 1999;70:85-90. (Pubitemid 29461117)
15. Shu XO, Zheng W, Potischman N, Brinton LA, Hatch MC, Gao YT, Fraumeni JF Jr. A population-based case-control study of dietary factors and endometrial cancer in Shanghai, People's Republic of China. Am J Epidemiol 1993;137:155-65.
16. Terry P, Wolk A, Vainio H, Weiderpass E. Fatty fish consumption lowers the risk of endometrial cancer: a nationwide case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 2002;11:143-5. (Pubitemid 34118325)
17. Xu WH, Dai Q, Xiang YB, Zhao GM, Zheng W, Gao YT, Ruan ZX, Cheng JR, Shu XO. Animal food intake and cooking methods in relation to endometrial cancer risk in Shanghai. Br J Cancer 2006;95:1586-92. (Pubitemid 44863365)
18. McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in western New York (United States). Cancer Causes Control 2000;11:965-74. (Pubitemid 32005307)
19. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997;57:5077-85. (Pubitemid 27498123)
20. Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993;71:3575-81. (Pubitemid 23152668)
21. Hirose K, Tajima K, Hamajima N, Takezaki T, Inoue M, Kuroishi T, Kuzuya K, Nakamura S, Tokudome S. Subsite (cervix/endometrium)- specific risk and protective factors in uterus cancer. Jpn J Cancer Res 1996;87:1001-9. (Pubitemid 26328928)
22. Jain MG, Howe GR, Rohan TE. Nutritional factors and endometrial cancer in Ontario, Canada. Cancer Control 2000;7:288-96. (Pubitemid 30387664)
23. Zheng W, Kushi LH, Potter JD, Sellers TA, Doyle TJ, Bostick RM, Folsom AR. Dietary intake of energy and animal foods and endometrial cancer incidence. The Iowa Women's Health Study. Am J Epidemiol 1995;142:388-94.
24. Arem H, Gunter MJ, Cross AJ, Hollenbeck AR, Sinha R. A prospective investigation of fish, meat and cooking-related carcinogens with endometrial cancer incidence. Br J Cancer 2013;109:756-60.
25. White E, Patterson RE, Kristal AR, Thornquist M, King I, Shattuck AL, Evans I, Satia-Abouta J, Littman AJ, Potter JD. VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 2004;159:83-93. (Pubitemid 38049425)
26. Patterson RE, Neuhouser ML, White E, Kristal AR, Potter JD. Measurement error from assessing use of vitamin supplements at one point in time. Epidemiology 1998;9:567-9. (Pubitemid 28387960)
27. Kristal AR, Feng Z, Coates RJ, Oberman A, George V. Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol 1997;146:856-69.
28. Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87. (Pubitemid 29144458)
29. University of Minnesota. Nutrient data system for research 2007-2-5. Minneapolis, MN: University of Minnesota, 2007.
30. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(suppl):1220S-31S.
31. Field RW, Smith BJ, Platz CE, Robinson RA, Neuberger JS, Brus CP, Lynch CF. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst 2004;96:1105-7. (Pubitemid 39172413)
32. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010;19:3119-30.
33. Pierce BL, Neuhouser ML, Wener MH, Bernstein L, Baumgartner RN, Ballard-Barbash R, Gilliland FD, Baumgartner KB, Sorensen B, McTiernan A, et al. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat 2009;114:155-67.
34. Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 2008;68:5619-27.
35. Kristal AR, Lampe JW. Prioritization of diet and cancer manuscripts: a brief primer. Cancer Epidemiol Biomarkers Prev 2011;20:725-6.
36. Bandera EV, Kushi LH, Moore DF, Gifkins DM, McCullough ML. Consumption of animal foods and endometrial cancer risk: a systematic literature review and meta-analysis. Cancer Causes Control 2007;18:967-88. (Pubitemid 47241092)
37. Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 2009;35:266-72.
38. Serini S, Fasano E, Piccioni E, Cittadini AR, Calviello G. Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects. Chem Res Toxicol 2011;24:2093-105.
39. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008;15:485-97. (Pubitemid 351880837)
40. Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42:3232-9. (Pubitemid 12041084)
41. Witt PM, Christensen JH, Ewertz M, Aardestrup IV, Schmidt EB. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2010;104:318-25.
42. Young LR, Raatz SK, Thomas W, Redmon JB, Kurzer MS. Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women. Nutr Metab (London) 2013;10:36.
43. Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer 2011;63:930-9.
44. Holloway AC, Stys KA, Foster WG. DDE-induced changes in aromatase activity in endometrial stromal cells in culture. Endocrine 2005;27:45-50. (Pubitemid 41112862)
45. Yoshizawa K, Brix AE, Sells DM, Jokinen MP, Wyde M, Orzech DP, Kissling GE, Walker NJ, Nyska A. Reproductive lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin and dioxin-like compounds. Toxicol Pathol 2009;37:921-37.
46. Weiderpass E, Adami HO, Baron JA, Wicklund-Glynn A, Aune M, Atuma S, Persson I. Organochlorines and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:487-93. (Pubitemid 30313891)
47. Hardell L, van Bavel B, Lindstrom G, Bjornfoth H, Orgum P, Carlberg M, Sorensen CS, Graflund M. Adipose tissue concentrations of p,p′-DDE and the risk for endometrial cancer. Gynecol Oncol 2004;95:706-11. (Pubitemid 39592541)
48. Horner NK, Patterson RE, Neuhouser ML, Lampe JW, Beresford SA, Prentice RL. Participant characteristics associated with errors in self-reported energy intake from the Women's Health Initiative food-frequency questionnaire. Am J Clin Nutr 2002;76:766-73.
49. Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33.
50. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33:159-71.